So, Futibatinib is this inhibitor that focuses on FGFR to help treat cholangiocarcinoma when FGFR2 fusions are involved. And it works by just stopping FGFR signaling. These tablets come in 4 mg doses.
They usually recommend taking 20 mg each day. The tablets come in bottles with 28 pills in each one.
Reviews
There are no reviews yet.